Erin Kopeny, PA
Medical · Arlington Heights, ILNPI 1053341743
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,331 of the $8,527 with a category attached, or 86.0%. It is spread thinly across 38 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $3,378 and has fallen 82.2% since, to $601 in 2025. Among medical clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 370 payments — averaging $23.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myovant Sciences Inc.$2K
- AbbVie$1K
- Mayne Pharma Commercial LLC$511
- Novo Nordisk$497
- Pfizer$471
- Amneal Pharmaceuticals LLC$399
- plus $4K from 32 others
What the payments were for
- Speaking & faculty fees$1,16214%
- Food & beverage$7,33186%
- Education$350%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myovant Sciences Inc. | 12 | $1,500 |
| AbbVie | 59 | $1,288 |
| Mayne Pharma Commercial LLC | 21 | $511 |
| Novo Nordisk | 21 | $497 |
| Pfizer | 24 | $471 |
| Amneal Pharmaceuticals LLC | 21 | $399 |
| Therapeuticsmd, Inc. | 37 | $382 |
| Sumitomo Pharma America, Inc. | 12 | $353 |
| Organon | 12 | $272 |
| Agile Therapeutics, Inc. | 14 | $268 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $231 |
| Exeltis, USA Inc. | 12 | $209 |
| Hologic Sales And Service, LLC | 11 | $209 |
| Astellas Pharma US Inc | 11 | $199 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $170 |
| Biogen | 8 | $159 |
| Lilly USA, LLC | 9 | $143 |
| Currax Pharmaceuticals LLC | 10 | $142 |
| Amgen | 8 | $134 |
| Biohaven Pharmaceuticals, Inc. | 3 | $122 |
| Aspira Women's Health Inc | 6 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $110 |
| Coopersurgical, Inc. | 5 | $83 |
| Radius Health, Inc. | 4 | $80 |
| Shield Therapeutics Inc | 4 | $78 |
| BD | 2 | $62 |
| Exact Sciences | 3 | $56 |
| Alfasigma USA, Inc. | 2 | $42 |
| Avion Pharmaceuticals | 3 | $37 |
| Dexcom, Inc. | 1 | $37 |
| Ascend Therapeutics US, LLC | 2 | $29 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Scynexis, Inc. | 1 | $22 |
| Abbott | 1 | $22 |
| Bayer | 1 | $20 |
| Millicent US Inc | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| IBSA Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORIAHNN$125
- Wegovy$122
- NEXTSTELLIS$118
- NURTEC ODT$106
- MYFEMBREE$102
How this compares
$8,527 in reported general payments places this provider in the 90th percentile of 449 medical providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 73 | $3,784 |
| ProgesteroneProgesterone, Micronized | 51 | $1,819 |
| Estradiol (Once Weekly)Estradiol | 17 | $907 |
| Metronidazole | 15 | $520 |
| Medroxyprogesterone Acetate | 13 | $503 |
| Levothyroxine Sodium | 66 | $329 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $279 |
| Rosuvastatin Calcium | 13 | $272 |
| ValacyclovirValacyclovir Hcl | 13 | $224 |
| Alprazolam | 21 | $127 |
| Alendronate Sodium | 19 | $107 |
| Fluconazole | 19 | $52 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $40 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $399 | $32966 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 449 medical providers in Illinois.
Other medical in Arlington Heights
- Tyler KosteckiArlington Heights$6K
- Thomas CottrellArlington Heights$5K
- Andrea TurekChicago$145K
- Priya BediElmhurst$56K
- Jennifer GarsonChicago$32K
- Bernice JohnsonPalos Heights$32K
- William KvasnickaChicago$19K
- Katie SpringerLake Forest$17K
- Matthew BrunoMorris$17K
- Kelly BrawleyBarrington$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.